Editas Medicine Newsroom

Clear Street Initiates Editas Medicine(EDIT.US) With Buy Rating, Announces Target Price $4

Futu NewsDec 19 18:36

Evercore Maintains Editas Medicine(EDIT.US) With Buy Rating, Cuts Target Price to $5

Futu NewsDec 16 21:33

Evercore ISI Group Maintains Outperform on Editas Medicine, Lowers Price Target to $5

BenzingaDec 16 21:30

J.P. Morgan Downgrades Editas Medicine(EDIT.US) to Sell Rating

Futu NewsDec 16 19:32

Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)

TipRanksDec 16 14:13

Morgan Stanley Maintains Editas Medicine(EDIT.US) With Hold Rating

Futu NewsDec 14 22:31

A Quick Look at Today's Ratings for Editas Medicine(EDIT.US), With a Forecast Between $3 to $3

Futu NewsDec 14 21:00

Editas Medicine Is Maintained at Sector Perform by RBC Capital

Dow JonesDec 14 01:38

Editas Medicine Maintains Hold Rating Amid Strategic Shifts and Financial Challenges

TipRanksDec 14 00:08

Barclays Maintains Equal-Weight on Editas Medicine, Lowers Price Target to $3

BenzingaDec 13 22:59

A Quick Look at Today's Ratings for Editas Medicine(EDIT.US), With a Forecast Between $3 to $8

Futu NewsDec 13 21:00

Baird Maintains Outperform on Editas Medicine, Lowers Price Target to $8

BenzingaDec 13 20:56

RBC Cuts Price Target on Editas Medicine to $4 From $5, Keeps Sector Perform, Speculative Risk

MT NewswiresDec 13 20:52

Editas Medicine Analyst Ratings

BenzingaDec 13 17:37

Barclays Keeps Their Hold Rating on Editas Medicine (EDIT)

TipRanksDec 13 16:30

Editas Medicine (EDIT) Receives a Buy From TD Cowen

TipRanksDec 13 11:43

Editas Medicine: Navigating Uncertainty With a Hold Rating Amid Strategic Shifts and Development Challenges

TipRanksDec 13 08:37

Editas Medicine Cut to Equal-Weight From Overweight by Wells Fargo

Dow JonesDec 11 21:33

Editas Medicine Analyst Ratings

BenzingaDec 11 21:24

Wells Fargo Maintains Editas Medicine(EDIT.US) With Hold Rating, Maintains Target Price $4

Futu NewsDec 11 20:32